Merus

Merus is focused on discovering and developing new treatments for cancer using their Multiclonics® Platform

Biotech & Life Sciences

Sector

Seed

Stage

Biotech

Model

01Company Overview

Merus is focused on discovering and developing new treatments for cancer using their Multiclonics® Platform.

02Backed By1 investor

03Recent Activity

Portfolio company Merus was acquired by Genmab in September 2025.

EXIT·racap.com

SEP 2025

04Similar Companies

A

I

GT

P

H

05Startup DNA

8

signals

Sectors
Business Model
Technology